VSL#3 & Vivomixx removed from Drug Tariff
Following a review by the Advisory Committee on Borderline Substances (ACBS) back in 2018, the probiotic food supplements VSL#3® and Vivomixx® were removed from Part XV of the Drug Tariff in England. The Committee concluded that the evidence did not sufficiently demonstrate that the products are clinically effective.
In NHSGGC, the ACBS approval process is used as guidance and therefore prescribing of these products within NHSGGC is not supported. Both VSL#3® and Vivomixx® are available for patients to purchase directly from the manufacturer.
Originally published 22/03/19 and updated 16/02/2022. Medicines Update blogs are correct at the time of publishing.